B-cell receptor (BCR) specific for rubella virus E1 and E2 envelope protein epitopes (BCR-RuV-E1/E2)

The B-cell receptor (BCR) specific for rubella virus E1 and E2 envelope protein epitopes is a critical component of the adaptive immune system's defense against rubella virus infection (PubMed: 16439534). These receptors are membrane-bound immunoglobulins expressed on the surface of B cells that specifically recognize and bind to the E1 and E2 glycoproteins, which are the primary surface proteins of the rubella virus (UniProt: P08563). E1 is the major immunodominant protein and the primary target for neutralizing antibodies, while E2 plays a role in viral attachment and entry (PubMed: 11831707). Upon binding to these viral epitopes, the BCR initiates intracellular signaling that drives B-cell activation, clonal expansion, and differentiation into antibody-secreting plasma cells and long-lived memory B cells (Janeway's Immunobiology). This process is the fundamental mechanism by which rubella vaccines, such as the MMR vaccine, confer long-term immunity (CDC). In the context of disease, these receptors are essential for preventing rubella infection and its severe complication, congenital rubella syndrome (CRS), which can cause significant birth defects (WHO). Therapeutic strategies focusing on these receptors primarily involve active immunization to elicit a robust and specific BCR repertoire that can neutralize the virus upon subsequent exposure. Understanding the specificity and affinity of these receptors is vital for developing next-generation vaccines and potential monoclonal antibody therapies.

Other names

Rubella virus-specific B-cell receptorAnti-rubella E1/E2 BCRRuV-specific BCRB-cell receptor for rubella E1/E2Anti-rubella BCR

The target acts as a sensor on the surface of B lymphocytes that binds specifically to epitopes on the rubella virus E1 and E2 glycoproteins, triggering signal transduction pathways that lead to B-cell proliferation, affinity maturation, and the secretion of neutralizing antibodies (PubMed: 16439534, Janeway's Immunobiology).